↓ Skip to main content

A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, April 2011
Altmetric Badge

Mentioned by

patent
18 patents

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
33 Mendeley
Title
A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion
Published in
Cancer Chemotherapy and Pharmacology, April 2011
DOI 10.1007/s00280-011-1621-0
Pubmed ID
Authors

Paul K. Paik, Leonard P. James, Gregory J. Riely, Christopher G. Azzoli, Vincent A. Miller, Kenneth K. Ng, Camelia S. Sima, Robert T. Heelan, Mark G. Kris, Erin Moore, Naiyer A. Rizvi

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 3%
Netherlands 1 3%
Unknown 31 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 15%
Student > Ph. D. Student 5 15%
Professor > Associate Professor 4 12%
Student > Master 4 12%
Other 3 9%
Other 7 21%
Unknown 5 15%
Readers by discipline Count As %
Medicine and Dentistry 11 33%
Pharmacology, Toxicology and Pharmaceutical Science 4 12%
Chemistry 3 9%
Biochemistry, Genetics and Molecular Biology 2 6%
Psychology 2 6%
Other 5 15%
Unknown 6 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2024.
All research outputs
#7,856,604
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#688
of 2,501 outputs
Outputs of similar age
#41,097
of 111,109 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#7
of 21 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 111,109 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.